These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3798067)

  • 1. [Is 1,25(OH)2D3 effective in chronic osteomyelofibrosis?].
    Eugster C; Brun del Re GP; Bucher U
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1767-70. PubMed ID: 3798067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome].
    Raya Sánchez JM; Hernández Nieto L; Brito Barroso ML; Hernández García MT
    Med Clin (Barc); 1994 Mar; 102(10):380-2. PubMed ID: 8182985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beneficial effect of 1,25-dihydroxyvitamin D3 in the treatment of myelofibrosis].
    Palomera L; García Díez I; Martínez R
    Med Clin (Barc); 1989 Sep; 93(7):265-8. PubMed ID: 2811498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1 alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts.
    Hyodo H; Kimura A; Nakata Y; Ohta H; Kuramoto A
    Int J Hematol; 1993 Apr; 57(2):131-7. PubMed ID: 8388271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for 1,25-dihydroxyvitamin D3 in control of bone-marrow collagen deposition?
    McCarthy DM; Hibbin JA; Goldman JM
    Lancet; 1984 Jan; 1(8368):78-80. PubMed ID: 6140427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of vitamin D3 and its metabolites 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on callus mineralization in rats with femoral fracture].
    Blazhevich NV; Sergeev IN; Arkhapchev IuP; Isaeva VA; Spirichev VB
    Vopr Med Khim; 1982; 28(6):98-105. PubMed ID: 6297167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the effects of alpha-25-dihydroxycholecalciferol and 24, 25-dihydroxycholecalciferol on calcium-phosphorus metabolism and on bone tissue in experimental kidney insufficiency in rats].
    Alekseeva AI; Spirichev VB; Bogoslovskiĭ NA; Kisel'nikova TA
    Vopr Med Khim; 1983; 29(5):103-12. PubMed ID: 6606264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosis.
    Foa P; Maiolo AT; Cortellaro M; Ortolani S; Pogliani E; Deliliers GL; Iurlo A; Zocchi L; Gualdoni A; Polli E
    Haematologica; 1990; 75(3):294-5. PubMed ID: 2227630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
    Gavrilov V; Steiner M; Shany S
    Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-Dihydroxy-vitamin D3 (1,25(OH)2D3) in the treatment of idiopathic myelofibrosis.
    Petrini M; Cecconi N; Azzara A; Ambrogi F; Grassi B
    Br J Haematol; 1986 Nov; 64(3):624-5. PubMed ID: 3790450
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on calcium homeostasis in rats treated with hydrocortisone].
    Karatabanova NA; Sokolova SV; Bogoslovskiĭ NA; Spirichev VB
    Vopr Med Khim; 1985; 31(3):112-6. PubMed ID: 3875180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 1,25-dihydroxy-vitamin D3(1,25(OH)2D3) in the treatment of idiopathic myelofibrosis.
    Eugster C; Brun del Re GP; Bucher U
    Br J Haematol; 1987 Mar; 65(3):381. PubMed ID: 3567092
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute myelofibrosis.
    Das S; Prabhakar BR
    Indian J Pathol Microbiol; 1997 Oct; 40(4):527-30. PubMed ID: 9444866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.